Fi­nan­cial­ly wob­bly opi­oid drug­mak­er In­sys agrees to pay $225M to set­tle gov­ern­ment probes

Af­ter be­ing found guilty of en­gag­ing in a bribery scheme to get doc­tors to pre­scribe its po­tent, ad­dic­tive painkiller and dup­ing in­sur­ers in­to pay­ing for the opi­oid drug by a fed­er­al ju­ry last month, for­mer ex­ec­u­tives of the con­tro­ver­sial In­sys Ther­a­peu­tics are be­ing held ac­count­able. The Phoenix, Ari­zona-based drug­mak­er $IN­SY has agreed to pay $225 mil­lion to set­tle the gov­ern­ment’s sep­a­rate crim­i­nal and civ­il in­ves­ti­ga­tions, the De­part­ment of Jus­tice (DoJ) said on Wednes­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.